Tag: Metabolic Diseases

April 14, 2026

Photoswitch Therapy Safe for Advanced Retinitis Pigmentosa: Phase 1 Trial Results

April 14, 2026

Elraglusib Combination Therapy Prolongs Survival in Metastatic Pancreatic Cancer

April 13, 2026

Proteomic Signatures for Predicting Menstrual Cycle Phases

April 7, 2026

Zodasiran siRNA Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

April 6, 2026

Neuroimaging Reveals Shared Brain Signature Across Five Major Psychedelics

April 6, 2026

Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: EMN24 IsKia Trial Results

April 4, 2026

Nourishing the World: The Need for Global Cross-Sector Collaboration

April 4, 2026

Renewed Tuberculosis Research Expands Drug and Vaccine Pipelines

April 4, 2026

Real-World Clinical Utility of Tumor Whole-Genome Sequencing in Solid Cancers

April 3, 2026

Monkeypox Virus Clade IIb Identified in Republic of the Congo

April 3, 2026

Social and Physical Exposures Linked to Accelerated Brain Aging

April 3, 2026

Target Product Profiles for Alzheimer’s Disease Prevention Therapies

April 2, 2026

Nature Medicine: Advancing Health Information Access

April 2, 2026

Semaglutide Reduces Cardiovascular Events by 20% in High-Risk Patients | SELECT Trial

March 31, 2026

Large-Scale Genetic Study Identifies Novel Autism Risk Genes & Common Biological Pathways

March 24, 2026

PANGEA-SMM: A Novel Prediction Model for Smoldering Multiple Myeloma Progression Across International Cohorts